Quick Answer
Beta Bionics, Inc. reported Common Stock Shares Outstanding of 44.36 million shares for the year ending 2025.
- Beta Bionics, Inc. showed an increase of +565.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Beta Bionics, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2025: 43.35 million shares | Q2 2025: 43.47 million shares | Q3 2025: 43.99 million shares.
- Historical annual values: Fiscal year 2025: 44.36 million shares | Fiscal year 2024: 6.67 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: